News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
The new SpotFire system is significantly faster than other CLIA-waived syndromic tests, and a new test menu could provide even more advantages, the firm said.
As the firm continues to develop assays to run on a current batch-based MDx system, it seeks to develop a more flexible, random-access testing platform.
BugSeq Bioinformatics Nabs BARDA Grant to Develop NGS-Based Respiratory Test
BugSeq will optimize a test for commercial clinical use by lowering the turnaround time, reducing interference from host RNA, and analytically validating the platform.
Polygenic Transcriptome Risk Scores for COPD Show Improved Cross-Ancestry Portability
Researchers found that polygenic transcriptome risk scores worked better across ethnicities than polygenic risk scores to predict chronic obstructive pulmonary disease risk.
Meridian Bioscience Gets Additional $2.5M NIH Award to Develop Revogene Respiratory Panel
The award comes after the company received $5.5 million from the agency last year to support the research, development, and increased production of the test.